• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

stockmammon's Profile

Avatar:

Membership:

Premium

Person Marks:

5

Total Posts:

35

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

1

Alias Born

07/13/2012 10:44:14 AM

Personal info

Recent Articles

• China's Central Bank Strategies for Sustaining Market Liquidity
• E.SUN's Climate Report: A Commitment to Nature and Sustainability
• Empowering Fintech Innovations Through Ralph Dangelmaier Scholarship
• Shimao Group Faces Liquidation Petition, Share Prices Plummet
• Praxis Precision Medicines Charts Course for Future Growth and Success
• Introducing Deye's Micro Hybrid ESS: Compact Future Power
• Global Oil Prices Surge Amid US Sanctions on Russian Exports
• Premier Investments Faces Major Setbacks Amid Retail Struggles
• Dollar Soars as Robust Jobs Data Strengthens U.S. Economy
• Analyzing Tariffs and Their Impact on the Freight Sector
• Japan and U.S. Leaders Discuss Steel Deal Concerns
• Merus and Biohaven Join Forces to Advance ADC Biotherapeutics
• Tune Therapeutics Secures Over $175M to Fuel Innovative Health Solutions
• Innovative Green Bond Initiative by NUS, Northern Trust, and UOB
• Critical Insights on Aircraft Leasing and Trade Dynamics
• Market Trends: Dollar Strengthens as Asian Stocks Dip
• Johnson & Johnson Evaluates Acquisition of Intra-Cellular
• Bezos Looks Forward to Trump’s Influence on Space Exploration
• Arowana's Achievement: A Leading Force in Impact Investing
• Exploring AI Innovations Elevating Healthcare Efficiency
• CIRCA Scientific Launches Innovative CrossWise Access System
• Japan's Wage Growth and Yen Weakness Prompt BOJ Inflation Concerns
• Natera Reports Strong Growth in 2024 Revenue and Testing Volume
• FutureMain Enhances AI Predictive Maintenance in Middle East
• Standard Chartered Faces Sanctions Over Bond Mis-Selling Issues
• Goldman Sachs Adjusts Federal Rate Cut Predictions for 2025
• Caribou Biosciences Launches Phase 1 Trial for Lupus Therapy
• Exact Sciences Reports Strong Q4 2024 Revenue Growth
• China Medical University Dominates at Taiwan National Awards
• WuXi AppTec Commits to Sustainable Pharmaceutical Practices
• Rising Oil Prices as US Sanctions Impact Russian Exports
• Insignia Financial Ltd's Bidding War Escalates with Bain Capital
• Market Outlook: Earnings and Inflation Influence Stock Trends
• Celebrating Literary Excellence: PenCraft Book Awards 2024
• Challenges of Air Travel Growth in Achieving Climate Goals
• Cellectar Biosciences Unveils 2025 Strategic Vision
• Castle Biosciences Reports Strong Growth in 2024 Performance
• Telix Expands Its Pipeline with Acquisition of ImaginAb Assets
• Ascendis Pharma's Strategic Roadmap and Milestones for Growth
• Market Outlook: Job Data Fuels Bond Yields, Impacts Stocks
• Ascendis Pharma Unveils Strategic Roadmap for Future Growth
• Telix Pharmaceuticals Strengthens Position with Key Acquisition
• Innovative Retail Tech Recognized in Upcoming NRF Report
• Revvity's Upcoming Earnings Call and Positive Financial Outlook
• Vertex Pharmaceuticals Unveils Key Pipeline Developments Ahead of Meetings
• Class Action Lawsuit Against Capri Holdings Limited: Join Now
• Opportunity for Investors in Caribou Biosciences, Inc. Lawsuit
• Enhanced Offer by Bain Capital Targets Insignia Financial's Future
• Amicus Therapeutics Announces Unprecedented Revenue Growth
• Exelixis Reveals 2024 Financial Performance and 2025 Outlook